Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation

Leukemia Research

Volumn 33, Issue 9, 2009, Pages 1217-1223

  Kaddar, T ^a   Chien, W W ^a   Bertrand, Y ^b   Pages, M P ^c   Rouault, J P ^d   Salles, G ^a   Ffrench, M ^a,c   Magaud, J P ^a,c  

^a Univ Claude Bernard   (France)

^b Institut d'Hématologie Oncologie Pédiatrique   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d CNRS   (France)

Author keywords

Acute lymphoblastic leukemia; Lymphocyte stimulation; miR 16; miR 16 targets; Prognosis

Indexed keywords

MICRORNA; MICRORNA 16; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B CELL LEUKEMIA; CHILD; CHILD CARE; CONTROLLED STUDY; CYTOGENETICS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; INFANT; LEUKOCYTOSIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREND STUDY;

ADOLESCENT; BLOTTING, NORTHERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; LYMPHOCYTES; MALE; MICRORNAS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 67649277420     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.12.015     Document Type: Article

References (36)

1. Ambros V. microRNAs: tiny regulators with great potential. Cell 107 (2001) 823-826
2. Lagos-Quintana M., Rauhut R., Lendeckel W., and Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294 (2001) 853-858
3. Lee R.C., and Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294 (2001) 862-864
4. Moss E.G. MicroRNAs: hidden in the genome. Curr Biol 12 (2002) 138-140
5. Lai E.C. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30 (2002) 363-364
6. Calin G.A., and Croce C.M. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25 (2006) 6202-6210
7. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New Engl J Med 353 (2005) 1793-1801
8. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
9. Marcucci G., Radmacher M.D., Maharry K., Mrózek K., Ruppert A.S., Paschka P., et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. New Engl J Med 358 (2008) 1919-1928
10. Kim V.N. Small RNAs: classification, biogenesis, and function. Mol Cells 19 (2005) 1-15
11. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., and Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 (2005) 839-843
12. Xi Y., Shalgi R., Fodstad O., Pilpel Y., and Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12 (2006) 2014-2024
13. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 447 (2007) 1130-1134
14. Woods K., Thomson J.M., and Hammond S.M. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282 (2007) 2130-2134
15. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40 (2008) 43-50
16. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukaemia. Proc Natl Acad Sci USA 99 (2002) 15524-15529
17. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102 (2005) 13944-13949
18. Linsley P.S., Schelter J., Burchard J., Kibukawa M., Martin M.M., Bartz S.R., et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27 (2007) 2240-2252
19. Calin G.A., Cimmino A., Fabbri M., Ferracin M., Wojcik S.E., Shimizu M., et al. MiR-15a and miR-16-1 cluster functions in human leukaemia. Proc Natl Acad Sci USA 105 (2008) 5166-5171
20. Chen R.W., Bemis L.T., Amato C.M., Myint H., Tran H., Birks D.K., et al. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112 (2008) 822-829
21. Liu Q., Fu H., Sun F., Zhang H., Tie Y., Zhu J., et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36 (2008) 5391-5404
22. Coustan-Smith E., Kitanaka A., Pui C.H., McNinch L., Evans W.E., Raimondi S.C., et al. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood 87 (1996) 1140-1146
23. Volm M., Koomägi R., Stammler G., Rittgen W., Zintl F., and Sauerbrey A. Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer 74 (1997) 508-512
24. Scuderi R., Palucka K.A., Pokrovskaja K., Björkholm M., Wiman K.G., and Pisa P. Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. Blood 87 (1996) 3360-3367
25. Mekki Y., Catallo R., Bertrand Y., Manel A.M., Ffrench P., Baghdassarian N., et al. Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Leukemia 13 (1999) 181-189
26. Wołowiec D., Mekki Y., Ffrench P., Manel A.M., Bertrand Y., Rimokh R., et al. Differential expression of cell proliferation regulatory proteins in B- and T-lineage acute lymphoblastic leukaemias. Br J Haematol 95 (1996) 518-523
27. Vilmer E., Suciu S., Ferster A., Bertrand Y., Cavé H., Thyss A., et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia 12 (2000) 2257-2266
28. Chebel A., Chien W.W., Gerland L.M., Mekki Y., Bertrand Y., Ffrench P., et al. Does p16ink4a expression increase with the number of cell doublings in normal and malignant lymphocytes?. Leuk Res 31 (2007) 1649-1658
29. Chen C., Ridzon D.A., Broomer A.J., Shout Z., Lee D.H., Nguyen J.T., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33 (2005) e179
30. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
31. Wołowiec D., Deviller P., Simonin D., Souchier C., Rimokh R., Benchaib M., et al. Cdk1 is a marker of proliferation in human lymphoid cells. Int J Cancer 61 (1995) 381-388
32. Reed J.C., Alpers J.D., Nowell P.C., and Hoover R.G. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc Natl Acad Sci USA 83 (1986) 3982-3986
33. Ajchenbaum F., Ando K., DeCaprio J.A., and Griffin J.D. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J Biol Chem 268 (1993) 4113-4119
34. Wołowiec D., Benchaib M., Pernas P., Deviller P., Souchier C., Rimokh R., et al. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia 9 (1995) 1382-1388
35. Wu H., Neilson J.R., Kumar P., Manocha M., Shankar P., Sharp P.A., et al. miRNA profiling of naïve, effector and memory CD8 T cells. PLoS ONE 2 (2007) e1020
36. Nam E.J., Yoon H., Kim S.W., Kim H., Kim Y.T., Kim J.H., et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14 (2008) 2690-2695